cbdMD EBIT

As of the most recent data (June 2026), YCBD shows a EBIT of $-800M. That compares with $-960K in the prior-year period — down 83238.0% year over year. That is below the Consumer Discretionary sector average of $150B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YCBD's EBIT is now $-800M (was $-960K) — a 83238.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether cbdMD is outperforming or lagging.

The Consumer Discretionary sector average EBIT is about $150B. cbdMD is at $-800M, which is lower that average. That is roughly 100.5% below the sector mean. Use the comparison chart on this page to see how YCBD stacks up against individual peers as well.

Tracking YCBD's ebit over time shows whether cbdMD is scaling, shrinking, or reshaping that part of the business. The current reading is $-800M That compares with $-960K in the prior-year period — down 83238.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has cbdMD's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-800M) with ownership activity and broader fundamentals.